Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes

Pathology and Oncology Research

Volumn 17, Issue 4, 2011, Pages 925-930

  Varga, Tímea ^a   Somogyi, Anikó ^a   Barna, Gábor ^b   Wichmann, Barna ^a   Nagy, Géza ^a   Rácz, Károly ^a   Selmeci, László ^b   Firneisz, Gábor ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

CD26; Dipeptidyl peptidase 4 (DPP 4); Glutamic acid decarboxylase antibody (GAD); Islet cell antibody (ICA); Type 1 diabetes (T1DM)

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; PANCREAS ISLET CELL ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BODY MASS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE MEMBRANE; MALE; T LYMPHOCYTE SUBPOPULATION;

ADULT; AUTOANTIBODIES; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL PEPTIDASE 4; FASTING; FEMALE; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN-SECRETING CELLS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 84855435744     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9404-9     Document Type: Article

References (24)

1. Gorrell MD, Gysbers V, McCaughan GW (2001) CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol 54:249-264 (Pubitemid 34205737)
2. Morimoto C, Schlossman SF (1998) The structure and function of CD26 in the T-cell immune response. Immunol Rev 161:55-70
3. Ohnuma K, Yamochi T, Uchiyama M, Nishibashi K, Iwata S, Morimoto C (2005) CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells. Mol Cell Biol 25:7743-7757 (Pubitemid 41170135)
4. Ikushima H, Munakata Y, Iwata S, Ohnuma K, Kobayashi S, Morimoto C (2002) Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor. Cell Immunol 215:106-110
5. Ohnuma K, Takahashi N, Yamochi T, Hosono O, Dang NH, Morimoto C (2008) Role of CD26/dipeptidyl peptidase IV in human T cell activation and function. Front Biosci 13:2299-2310 (Pubitemid 351589255)
6. Ohnuma K, Dang NH, Morimoto C (2008) Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Trends Immunol 29(6):295-301
7. Stone SF, Lee S, Keane NM, Price P, French MA (2002) Association of increased Hepatitis C Virus (HCV)-Specific IgG and soluble CD26 Dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients. J Infect Dis 186:1498-1502 (Pubitemid 35286121)
8. Kobayashi H, Hosono U, Mimori T, Kawasaki H, Hoang Dang N, Tanaka H, Morimoto C (2000) Reduction of serum soluble CD26/ dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus. J Rheumatol 29 (9):1858-1866 (Pubitemid 34988693)
9. Cordero OJ, Salgado FJ, Meravarela A, Nogueira M (2001) Serum interleukin-12, interleukin- 15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis. Rheumatol Int 21:69-74 (Pubitemid 33036135)
10. Schonermarck U, Csernok E, Trabandt A, Hansen H, Gross WL (2000) Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA associated vasculitides. Clin Exp Rheumatol 18:457-463 (Pubitemid 30616941)
11. Firneisz G, Lakatos PL, Szalay F, Hungarian Viral Hepatitis Study Group (2001) Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C. Scand J Gastroenterol 36:877-880 930 T. Varga et al (Pubitemid 32656564)
12. Lefebvre J, Murphey LJ, Hartert TV, Jiao Shan R, Simmons WH, Brown NJ (2002) Dipeptidyl peptidase IVactivity in patients with ACE-inhibitor associated angioedema. Hypertension 39:460-464 (Pubitemid 34165165)
13. Stancikova M, Lojda Z, Lukac J, Ruzickova M (1992) Dipeptidyl peptidase IV in patients with systemic lupus erythematosus. Clin Exp Rheumatol 10:381-385
14. Blazquez MV, Madueno JA, Gonzalez R, Jurado R, Bachovchin WW, Pena J, Munoz E (1992) Selective decrease of CD26 expression in T cells from HIV-1-infected individuals. J Immunol 149(9):3073-3077
15. Jones D, Dang NH, Duvic M, Washington LT, Huh YO (2001) Absence ofCD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 115(6):885-892 (Pubitemid 32476716)
16. Firneisz G, Varga T, Lengyel G, Fehér J, Ghyczy D, Wichmann B, Selmeci L, Tulassay Zs, Rácz K, Somogyi A (2010) Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: A novel liver disease biomarker. PLOS One 5(8):e12226
17. Varga Tet al (2008) Higher serum dipeitidyl peptidase-4 activity in type 1 diabetes mellitus than in type 2: A direct comparison. Diabetologia 51(Suppl 1):S239, A589
18. Selmeci L, Szokodi I, Horvat-Karajz K (1996) A sensitive microplate-based continuous monitoring (kinetic) assay for serum neutral endopeptidase (EC 3.4.24.11) activity. Clin Chim Acta 244:111-116 (Pubitemid 26050203)
19. Ellis SL, Moser EG, Snell-Bergeon JK, Gutin RS, Rodionova AS, Garg SK (2010) Effect of sitagliptin on glucose control in patients with type 1 diabetes- a pilot study. Diabetologia 53:S39, A77
20. Andrieu T, Thibault V, Malet I, Laporte J, Bauvois B, Agut H, Cahour A (2003) Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections. J Clin Virol 27:59-68 (Pubitemid 36513590)
21. Hadjiyanni I, Siminovitch KA, Danska JS, Drucker DJ (2010) Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells. Diabetologia 53:730-740
22. Morran MP, Omenn GS, Pietropaolo M (2008) Immunology and genetics of type 1 diabetes. Mt Sinai J Med 75(4):314-327
23. Hafler DA, Fox DA, Manning ME, Schlossman SF, Reinherz EL, Weiner HL (1985) In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 312:1405-1411
24. Ohnuma K, Inoue H, Uchiyama M, Yamochi T, Hosono OD, Nam H, Morimoto C (2006) T-cell activation via CD26 and caveolin-1 in rheumatoid synovium. Mod Rheumatol 16:3-13